6 completed, 1 active not recruiting, 1 recruiting, 1 unknown. 2 Not applicable, 2 Phase 4, 1 Early Phase 1, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 4 | 2 | Completed 1, Unknown 1 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Hyperlipoproteinemia Type IV: new trials by email Literature Review of Hyperlipoproteinemia Type IV trials Research Report on Hyperlipoproteinemia Type IV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Evaluation of Gene Therapy Drug in the Treatment of Primary Hypertriglyceridemic Patients With Recurrent Pancreatitis GC304 - Hypertriglyceridemia, Familial | Phase 1 | Recruiting | GeneCradle Inc | 7 | 2024-09-20 | 2025-07-03 |
| Milk as a Recovery Beverage After Exercise for Improving Metabolic Health Exercise, Drink - Hyperlipemia, Carbohydrate Inducible | Not applicable | Completed | University of Saskatchewan | 20 | 2017-05-20 | 2019-05-07 |
| Effects of Exercise on Fructose-induced Postprandial Lipemia FRUCTOSE, DEXTROSE, EXERCISE - Sedentary Lifestyle, Dyslipidemias | Not applicable | Completed | Federal University of Rio Grande do Sul | 12 | 2016-01-10 | 2017-06-01 |
| Triglyceride Lowering Study Omega-3-Acid Ethyl Esters - Hypertriglyceridemia | Phase 4 | Unknown | Jewish Hospital, Cincinnati, Ohio | 25 | 2009-07-01 | 2009-07-08 |
| Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients rosuvastatin - Hypertriglyceridemia, Hyperlipoproteinemia Type IV | Phase 4 | Completed | AstraZeneca | 334 | 2007-01-01 | 2010-12-16 |
| A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides torcetrapib/atorvastatin, atorvastatin - Hypertriglyceridemia, Hyperlipoproteinemia Type IV | Phase 3 | Completed | Pfizer | 160 | 2005-02-01 | 2007-11-16 |
| Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism chenodeoxycholic acid, placebo capsules - Metabolic Syndrome, Familial Hypertriglyceridemia | Early Phase 1 | Completed | University Hospital, Basel, Switzerland | 30 | 2004-10-01 | 2012-03-09 |
| Stockholm hyperTRIglyceridemia REGister (STRIREG) Study Heredity for cardiovascular disease, Heredity for pancreatitis, Heredity for type 2 diabetes - Familial Hypertriglyceridemia | Active not recruiting | Region Stockholm | 3607819 | 2000-01-01 | 2023-10-27 | |
| Genetic Epidemiology of Hypertriglyceridemia Cardiovascular Diseases, Coronary Disease | Completed | University of Washington | 1993-07-01 | 2016-02-10 |
Hypertriglyceridemia (3) · Hyperlipidemia, Familial Combined (2) · Cardiovascular Diseases (1) · Coronary Disease (1) · Dyslipidemias (1) · Hyperlipidemias (1) · Hyperlipoproteinemia Type II (1) · Hyperlipoproteinemia Type V (1) · Hyperlipoproteinemias (1) · Lipid Metabolism Disorders (1) · Metabolic Syndrome (1) · Motor Activity (1) · Sedentary Behavior (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9) · Genetic Diseases, Inborn (9) · Lipid Metabolism, Inborn Errors (9) · Metabolic Diseases (9) · Metabolism, Inborn Errors (9) · Nutritional and Metabolic Diseases (9) · Dyslipidemias (8) · Hyperlipidemias (8) · Hyperlipoproteinemias (8) · Lipid Metabolism Disorders (8) · Hypertriglyceridemia (6) · Behavior (1) · Glucose Metabolism Disorders (1) · Heart Diseases (1) · Hyperinsulinism (1)
Exercise (2) · Atorvastatin (1) · Chenodeoxycholic Acid (1) · Fructose (1) · Glucose (1) · Heredity (1) · Omacor (1) · Rosuvastatin Calcium (1) · torcetrapib (1)
AstraZeneca (1) · Federal University of Rio Grande do Sul (1) · GeneCradle Inc (1) · Jewish Hospital, Cincinnati, Ohio (1) · Pfizer (1) · Region Stockholm (1) · University Hospital, Basel, Switzerland (1) · University of Saskatchewan (1) · University of Washington (1)
Canada (2) · United States (2) · China (1) · Mexico (1) · Switzerland (1)
Ana Polanco, MD (1) · Charles Glueck, MD (1) · Juan Talavera, MD (1) · Melissa Austin (1) · Philip Chilibeck, PhD (1) · Stefan Bilz, MD (1)
R01HL049513 (1)